WELCOME
Welcome to the ESH eLearning Centre!
  • Our goal is to share knowledge regarding the world of haematology.
  • With our conferences, we connect professionals all around the world.
  • With this platform, we allow everyone to relive the talks and discussions of our events for free!

Welcome to the ESH eLearning Centre!

ESH believes it is very important to allow specialists to gain new knowledge, competencies, and skills or to brush up on acquired ones at a time and place of their choosing.
 

The ESH eLearning platform comprises freely accessible:

→ on-demand components from ESH Conferences (slide bank, video presentations/ webcast, and discussions) ; whether you cannot attend live events because of time, mobility, financial or other restraints, or you simply wish to review content presented at a session you attended

→ as well as quizzes, learning tools, interviews, abstracts, documents and articles.
 

Stay updated:

→ Sign up for ESH Newsletter

→ Follow us on ESH social media (X, Facebook, LinkedIn)
UPCOMING CONFERENCES
ESH upcoming conferences
  • February 27-March 01, 2026 - Mandelieu-La Napoule: ESH 5th How to Diagnose and Treat: Acute Leukaemias
  • March 05-07, 2026 - 4th Translational Research Conference: Chronic Lymphocytic Leukaemia
  • March 26-28, 2026 - 8th Translational Research Conference: Multiple Myeloma
  • Click on "learn more" to access the full ESH upcoming conference agenda

ESH provides a diverse portfolio of leading-edge scientific, translational research and clinically oriented meetings at which outstanding international faculties actively inform, mentor and interact face to face with practicing biologists and clinicians from across the world.  

→ Ample time is deliberately provided for in-depth scientific discussion and interaction. 

→ Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks.

→ ESH conference delegates are invited to submit abstracts. Selected abstracts are presented as brief oral communications or posters.

 

ESH upcoming conference agenda comprises:

- Scientific Workshops: 

→ organized in rapidly evolving scientific fields
 

- Translational Research Conferences:

→ disease-specific
→  focus on leading-edge basic, clinical and therapeutic research and future perspectives. 

→ the presentation of unpublished data is encouraged.
 

- “How to Diagnose and Treat” Conferences:

→ disease-specific
→ emphasize clinical management, including future perspectives

→ use case-based lectures to stimulate interaction
SPECIFIC DISEASES
Browse content by your topic(s) of interest
  • Leukaemias
  • Myelomas
  • Immune therapies and others…
STAY TUNED
OPEN CONTENT
  • Find all our open content without logging-in
7th International Conference: Acute Myeloid Leukemia
7th International Conference: Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment
  • Chairs : Hartmut Döhner, Benjamin Ebert, Bob Löwenberg
  • October 16-18, 2025

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from January 18th, 2026! 

On-demand industry Symposium already freely available to all! 

 

MAIN SCIENTIFIC TOPICS:

• PREDISPOSITION AND AGING
• CLONAL HEMATOPOIESIS
• TARGETING CLONAL HEMATOPOIESIS
• THERAPEUTIC TARGETING 1
• METABOLIC AND PROTEOMIC ALTERATIONS
• CELLULAR THERAPY
• THERAPEUTIC TARGETING 2
• MEASURABLE RESIDUAL DISEASE IN AML
• THERAPEUTIC TARGETING 3
• THERAPEUTIC TARGETING 4

 

 

 


FACULTY MEMBERS:

Kelly BOLTON (St Louis), Steven CHAN (Toronto), Simona COLLA (Houston), Charles CRADDOCK (Birmingham), Ruud DELWEL (Rotterdam), Courtney DiNARDO (Houston), John DiPERSIO (St. Louis), Hartmut DÖHNER (Ulm), Konstanze DÖHNER (Ulm), Benjamin EBERT (Boston), Brunangelo FALINI (Perugia), Saar GILL (Philadelphia), Christopher HOURIGAN (Washington), Gerwin HULS (Groningen), Brian HUNTLY (Cambridge), Siddartha JAISWAL (Stanford), Courtney JONES (Cincinnati), Marina KONOPLEVA (New York), Andrew LANE (Boston), Bob LÖWENBERG (Rotterdam), Els MANSELL (Rotterdam), Markus MANZ (Zürich), Adam MEAD (Oxford), Eirini PAPAPETROU (New York), Alexandre PUISSANT (Paris), Eytan STEIN (New York), Zuzana TOTHOVA (Boston), Peter VALK (Rotterdam), Paresh VYAS (Oxford), Andrew WEI (Melbourne), Marcin WLODARSKI (Memphis), Sebastian WOLF (Frankfurt), Joshua ZEIDNER (Chapel Hill)

27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
  • Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause
  • October 10-12, 2025

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from January 12th, 2026!
On-demand industry Symposium already freely available to all! 

MAIN SCIENTIFIC TOPICS:

– Stem Cells
– Cell biology
– Biomarkers, resistance and new targets
– New drugs and clinical trials
– CML special scenarios
– Myeloproliferative Neoplasms 
– Mitochondria biology
– Clonal tracking
– Treatment free remission
– Immunology

FACULTY MEMBERS:

Alexander ANDERSON (Tampa), Jane APPERLEY (London), Ravi BHATIA (Birmingham), Carla Maria BOQUIMPANI (Rio de Janeiro), Susan BRANFORD (Adelaide), Massimo BRECCIA (Rome), Tim BRÜMMENDORF (Aachen), Fausto CASTAGNETTI (Bologna), Ekaterina CHELYSHEVA (Moscow), Stefan CONSTANTINESCU (Brussels), Mhairi COPLAND (Glasgow), Jorge CORTES (Augusta), Antonio DE ALMEIDA (Lisbon), Michael DEININGER (Milwaukee), Hervé DOMBRET (Paris), Alessandro DONADA (Paris), Marieke ESSERS (Heidelberg), Briandy FERNANDEZ-MARRERO (El Paso), Robert Peter GALE (London), Payam GAMMAGE (Glasgow), Ian GANLEY (Dundee), François GUILHOT (Poitiers), Stein-Erik GULLAKSEN (Bergen), Olivier HANTSCHEL (Marburg), Vignir HELGASON (Glasgow), Andreas HOCHHAUS (Jena), Tim P. HUGHES (Adelaide), Henrike JACOBI (Aachen), Dan S. KAUFMAN (La Jolla), David KENT (York), Dennis KIM (Toronto), Takeshi KONDO (Sapporo), Daniela KRAUSE (Mainz), Elias LAGONIK (Adelaide), Fabian LANG (Frankfurt), Inga LESKE (Marburg), Ariel LEYTE-VIDAL (San Francisco), Weiming LI (Wuhan), Nienke LOKHORST (Nijmegen), François-Xavier MAHON (Bordeaux), Els MANSELL (Rotterdam), John MASCARENHAS (New York), Dragana MILOJKOVIC (London), Nirmalya Roy MOULIK (Mumbai), Satu MUSTJOKI (Helsinki), John Joson NG (Singapore), Vivian OEHLER (Seattle), Sin Tiong ONG (Singapore), Nicholas A. OTHIENO-ABINYA (Nairobi), Ilaria S. PAGANI (Adelaide), Paolo PICCALUGA (Bologna), Yasmine POBIEDONOSCEW (Bordeaux), Jerald RADICH (Seattle), Delphine REA (Paris), Tiffany RICKETTS (Birmingham), David ROSS (Adelaide), Daniele SARNELLO (Glasgow), Mirle SCHEMIONEK-REINDERS (Aachen), Micael SCHERER (Heidelberg), Mary SCOTT (Glasgow), Stephanie SEMBILL (Erlangen), Simona SOVERINI (Bologna), Kendra SWEET (Tampa), David VETRIE (Glasgow), Margherita VIERI (Aachen), Gerlinde WERNIG (Stanford), Deborah WHITE (Adelaide), Daniela ZACKOVA (Brno), Xiaoshuai ZHANG (Beijing)
8th Translational Research Conference Lymphoid Malignancies
8th Translational Research Conference: Lymphoid Malignancies
  • Chairs : Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt, Catherine Wu
  • October 2-4, 2025

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from January 4th, 2026!
 

MAIN SCIENTIFIC TOPICS:

• Biology of lymphoma
• Clonal evolution
• Lymphoma cell interactions in the tumor microenvironment 
• Monoclonal antibodies & non-cellular immune therapies
• Cellular immune therapies
• Small molecular pathway inhibitors
• Development of novel treatment paradigms
• Novel Bio markers for diagnostic and therapeutic monitoringBiology of lymphoma

FACULTY MEMBERS:

Jennifer G. ABELIN (Cambridge), Ash ALIZADEH (Stanford), Veronika BACHANOVA (Minneapolis), Elias CAMPO (Barcelona), Paula CRAMER (Cologne), Riccardo DALLA-FAVERA (New York), Parry ERIN (Boston), Toby E. EYRE (Oxford), Matthew J. FRANK (Stanford), Sai GOURISANKAR (Stanford), Michael GREEN (Houston), Michael HALLEK (Cologne), Martin HUTCHINGS (Copenhagen), Jared JOHNSON (Boston), Georg LENZ (Münster), Nathalie JAVIDI-SHARIFI (Boston), José Ignacio MARTÍN-SUBERO (Barcelona), Ari MELNICK (Barcelona), Ryan MORIN (Burnaby), Natarajan MUTHUSAMY (Columbus), Thomas OELLERICH (Frankfurt), Teresa PALOMERO (New York), Scott RODIG (Boston), Sandrine ROULLAND (Marseille), Florian SCHERER (Freiburg), Laurie SEHN (Vancouver), Martina SEIFFERT (Heidelberg), Louis STAUDT (Bethesda), Catherine THIEBLEMONT (Paris), Wyndham WILSON (Bethesda), Catherine WU (Boston)

3rd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients
3rd How I Manage CAR-T Therapies and Bispecific Antibodies for my Patients
  • Chairs: Caron Jacobson, Ulrich Jäger, Marie José Kersten
  • September 26-28, 2025

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from December 28th, 2025!

MAIN SCIENTIFIC TOPICS:

• Non-hodgkin lymphoma
• Multiple myeloma
• Novel indications of CAR T-cell therapy
• CAR-T vs bispecific antibody in multiple myeloma
• Access to CAR-T and bispecific across the globe
• Mechanism of action and resistance to bispecifics
• Predictors of response and toxicity of CAR
and bispecific
• Access issues in CAR T-cell treatment
• 1st line high-risk large B-cell lymphoma
• Real world data for CAR-T and bispecific
• Next Generation of CAR T-cell
and bispecific antibody therapy
• Outsmarting the Escape Artist:
resistance to CART immunotherapy

FACULTY MEMBERS:

Natacha BOLANOS (Madrid) Lucila NASSIF KERBAUY (São Paulo) Jonathan CLARK (Loosdrecht) Elise PENNINGS (Amsterdam) Peter DREGER (Heidelberg) Michelle POON (Singapore) Guido GHILARDI (Bellinzona) Carlos RAMOS (Houston) Candice HENDRICKS (Pretoria) Kai REJESKI (New York) Roch HOUOT (Rennes) Claire RODDIE (London) Johannes HUPPA (Berlin) Marco RUELLA (Philadelphia) Caron JACOBSON (Boston) Hans Ulrich SCHERER (Leiden)  Ulrich JÄGER (Vienna) Yasmina SERROUKH (Rotterdam) Philipp KARSCHNIA (Erlangen) Marion SUBKLEWE (Munich) Marie José KERSTEN (Amsterdam) Catherine THIEBLEMONT (Paris) Anne Marijn KRAMER (Stanford) Max TOPP (Würzburg)  Maria KRAUTH (Vienna) Alvaro URBANO-ISPIZUA (Barcelona) Frederick LOCKE (Tampa) Saad USMANI  (New York) Maik LUU (Würzburg) Niels VAN DE DONK (Amsterdam)

 

ABOUT THE CONFERENCE:

The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants.

In addition to the scientific and medical issues addressed during the conference, the questions of affordability and access to these novel expensive treatments will be tackled.

This educational conference has been approved for 17 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!
4th Translational Research Conference: Acute Lymphoblastic Leukaemia
4th Translational Research Conference: Acute Lymphoblastic Leukaemia
  • Chairs : Kathrin Bernt, Jan Cools, Hervé Dombret, Ulla Wartiovaara-Kautto
  • May 22-24, 2025

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from August 24th, 2025!

MAIN SCIENTIFIC TOPICS:
 

• The biology of T-ALL
• The biology of B-cell precursor ALL subtypes
• Specific genetic entities
• Host factors
• Measurable Residual Disease (MRD)
• Targeted therapy
• Immunotherapy
• Cell therapy
• Other potential ALL targets

FACULTY MEMBERS:

Smita BHATIA (Birmingham), Tina BHATLA (Newark), Nicolas BOISSEL (Paris), Monika BRÜGGEMANN (Kiel), Sabina CHIARETTI (Rome), Emmanuelle CLAPPIER (Paris), Jan COOLS (Leuven), Monique DEN BOER (Utrecht), Hervé DOMBRET (Paris), Rong FAN (New Haven), Sara GHORASHIAN (London), Nicola GÖKBUGET (Frankfurt), Ilaria IACOBUCCI (Memphis), Christian KRATZ (Hannover), James LABELLE (Chicago), Marc R. MANSOUR (London), Charles MULLIGHAN (Memphis), Triona NI-CHONGHAILE (Dublin), Rayne H. ROUCE (Houston), Philippe ROUSSELOT (Versailles), Lisa RUSSELL (Newcastle), Takaomi SANDA (Nagoya), Owen P. SMITH (Dublin), Izidor SOSIC (Ljubljana), Sarah K. TASIAN (Utrecht), David T. TEACHEY (Philadelphia), Ulla WARTIOVAARA-KAUTTO (Helsinki), Jun J. YANG (Memphis)​

ABOUT THE CONFERENCE:

ESH Translational Research Conference programmes are designed to place emphasis on lleading-edge basic, clinical and therapeutic research and future perspectives. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks. ESH conference delegates are invited to submit abstracts. Selected abstracts are presented as brief oral communications or posters.

 
We found no results for your search. Please change or remove at least one filter to broaden your search.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies